CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-27 | ALCORN HARRY W JR Chief Medical Officer | Purchase | +150 | $4.46 | $668 | 1,150 |
| 2018-12-11 | Xiao Zhenyu Director | Purchase | +3,250 | $4.00 | $13K | 7,100 |
| 2018-12-11 | Verdoorn Todd A. Chief Scientific Officer | Purchase | +1,000 | $4.00 | $4K | 2,000 |
| 2018-12-11 | Pilnik Richard D. Director | Purchase | +6,250 | $4.00 | $25K | 23,838 |
| 2018-12-11 | Pauls Dietrich John President and CEO | Purchase | +5,000 | $4.00 | $20K | 29,804 |
| 2018-12-11 | Parsons James T. Director | Purchase | +2,250 | $4.00 | $9K | 6,100 |
| 2018-12-11 | Kellen Scott CFO and Secretary | Purchase | +1,250 | $4.00 | $5K | 3,290 |
| 2018-12-11 | Giuffre Randall Michael Director | Purchase | +11,250 | $4.00 | $45K | 85,804 |
| 2018-12-11 | ALCORN HARRY W JR Chief Medical Officer | Purchase | +1,000 | $4.00 | $4K | 1,000 |
Page 10 of 10 · 189 trades